Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salivary TNF-alpha in Oral Lichen Planus Treated With Topical Clobetasol vs Fluocinolone
TCTR20220705003Phase 4Completed
- Sponsor
- Faculty of Dentistry, Chiang Mai University
- Start
- Jul 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in oral lichen planus (OLP) comparing Topical clobetasol propionate with Topical fluocinolone acetonide (2 arms). Primary endpoint: Change in salivary TNF-alpha levels. Started Jul 2022; status: completed.
02
Drugs
clobetasolfluocinolone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on TCTR20220705003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220705003.